Goldman Sachs’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $601K | Sell |
|
|||||
|
2025
Q1 | $2.2M | Sell |
|
|||||
|
2024
Q4 | $8.77M | Buy |
|
|||||
|
2024
Q3 | $7.21M | Buy |
|
|||||
|
2024
Q2 | $5.46M | Buy |
|
|||||
|
2024
Q1 | $8.27M | Buy |
|
|||||
|
2023
Q4 | $15.6M | Sell |
|
|||||
|
2023
Q3 | $14.1M | Sell |
|
|||||
|
2023
Q2 | $32.7M | Buy |
|
|||||
|
2023
Q1 | $26.9M | Sell |
|
|||||
|
2022
Q4 | $20.8M | Sell |
|
|||||
|
2022
Q3 | $21.2M | Sell |
|
|||||
|
2022
Q2 | $37.3M | Buy |
|
|||||
|
2022
Q1 | $26.4M | Buy |
|
|||||
|
2021
Q4 | $54.7M | Buy |
|
|||||
|
2021
Q3 | $60.4M | Sell |
|
|||||
|
2021
Q2 | $91.9M | Buy |
|
|||||
|
2021
Q1 | $40.6M | Buy |
|
|||||
|
2020
Q4 | $7M | Sell |
|
|||||
|
2020
Q3 | $4.11M | Sell |
|
|||||
|
2020
Q2 | $3.17M | Sell |
|
|||||
|
2020
Q1 | $8M | Sell |
|
|||||
|
2019
Q4 | $16.5M | Sell |
|
|||||
|
2019
Q3 | $16.6M | Sell |
|
|||||
|
2019
Q2 | $32M | Buy |
|
|||||
|
2019
Q1 | $20.7M | Buy |
|
|||||
|
2018
Q4 | $19.6M | Buy |
|
|||||
|
2018
Q3 | $1.19M | Buy |
|
|||||
|
2018
Q2 | $566K | Sell |
|
|||||
|
2018
Q1 | $490K | Buy |
|
|||||
|
2017
Q4 | $402K | Buy |
|
|||||
|
2017
Q3 | $729K | Sell |
|
|||||
|
2017
Q2 | $534K | Buy |
|
|||||
|
2017
Q1 | $625K | Sell |
|
|||||
|
2016
Q4 | $915K | Buy |
|
|||||
|
2016
Q3 | $1.65M | Buy |
|
|||||
|
2016
Q2 | $527K | Buy |
|
|||||
|
2016
Q1 | $580K | Sell |
|
|||||
|
2015
Q4 | $2.36M | Buy |
|
|||||
|
2015
Q3 | $217K | Sell |
|
|||||
|
2015
Q2 | $493K | Buy |
|
|||||
|
2015
Q1 | $419K | Buy |
|
|||||
|
2014
Q4 | $358K | Sell |
|
|||||
|
2014
Q3 | $1.88M | Buy |
|
|||||
|
2014
Q2 | $385K | Buy |
|
|||||
|
2014
Q1 | $164K | Buy |
|
|||||
|
2013
Q4 | $64K | Buy |
|
|||||
|
2013
Q3 | $61K | Buy |
|